2022 healthcare megatrends shaping IVD 2022 healthcare megatrends shaping IVD… In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT) | Asia | Europe | Middle East & Africa | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
Rapid antigen tests to erode PCR-based molecular covid test market in APAC Emergent covid-19 screening technologies coupled with… Covid-19 testing | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Molecular diagnostics instrument sales in Asia-Pacific set to normalise as vaccination rates rise Molecular diagnostics (MDX) instrument sales in Asia-Pacific… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: Molecular testing capacity expands in Asia-Pacific Molecular diagnostics (MDx) testing capacities and… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Point-of-care vs. lab-based covid-19 testing Covid-19 testing has emerged as a top priority for clinical… In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
Keeping ahead of infectious diseases in Asia-Pacific with increased testing Our new briefing paper looks at the testing trends in… Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
[On-demand Webinar] Covid-19 Impact: Molecular Diagnostic (MDx) Market EIU Healthcare zooms in on two of the fastest-growing… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Europe | Global | IVD Gateway | Molecular Diagnostics (MDx)